OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Infectious Diseases is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Potential opportunities and challenges for infection prevention and control for cystic fibrosis in the modern era	63
Hematopoietic stem cell transplantation and cellular therapy in persons living with HIV	58
Surgical management of cystic echinococcosis of the liver	57
Skin and soft tissue infections: swab or biopsy? A diagnostic dilemma	50
Corticosteroids for viral central nervous system infections	48
Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside	45
From diagnosis to management: current perspectives on congenital cytomegalovirus infection	43
Complexities of cardiomyopathy in septic shock	41
Postexposure prophylaxis for occupational exposure to selected pathogens for healthcare personnel	38
Skin and soft tissue infections in the elderly	33
Strongyloidiasis-related lung involvement: too much of a bad thing	33
Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients	32
La Crosse virus encephalitis in children	32
Babesiosis in immunosuppressed hosts: pathogenesis, diagnosis and management	31
Tissue resident memory T cells in respiratory infections	30
Managing cognitive impairment in people with HIV: Erratum	30
Viral meningitis and encephalitis: an update	30
Typhoid fever control in the 21st century: where are we now?	30
Bacterial cholesterol-dependent cytolysins and their interaction with the human immune response	29
Fusarium species central nervous system infection	28
Tuberculosis molecular bacterial load assay in the management of tuberculosis	27
The reemergence of Streptococcus pyogenes in skin and soft tissue infections: a review of epidemiology, pathogenesis, and management strategies	26
Mpox in people living with HIV	26
Follow-up blood culture in Gram-negative bacilli bacteraemia: for whom is follow-up blood culture useful?	24
Resistant herpes simplex virus infections – who, when, and what's new?	23

Malaria in pregnancy: baby steps	23
Tropical infectious diseases and skin manifestations: a diagnostic framework	23
Tick-borne encephalitis	22
Does climate change threaten delivery of HIV care in resource-limited settings?	21
Mitigation of nontuberculous mycobacteria in hospital water: challenges for infection prevention	21
Appropriate surgical management in skin and soft tissue infections	20
Editorial introductions	20
Diagnostic stewardship: what impacts antibiotics use?	19
Using antibiotics wisely	18
Interventions for polyoma virus-associated hemorrhagic cystitis	18
Haemophilus ducreyi in genital ulcer disease: new developments in an old disease	17
CMV antiviral stewardship in transplantation – the next frontier	17
Management of neonates born to mothers with active genital herpes simplex virus infection: an alternative approach	17
Diagnostic approach and update on encephalitis	17
New diagnostic strategies to distinguish Crohn's disease and gastrointestinal tuberculosis	16
How to differentiate skin rash in covid, mononucleosis, chickenpox, sixth disease and measles	16
Gut microbiome and its clinical implications: exploring the key players in human health	16
Prenatal and postnatal antiviral therapies for the prevention and treatment of congenital cytomegalovirus infections	16
Risk stratification for selecting empiric antibiotherapy during and after COVID-19	16
Update on the treatment of chronic pulmonary aspergillosis	16
Recent advances in flavivirus encephalitis	16
Large lessons learned from small vessels: coronary microvascular dysfunction in HIV	16
The plumbing problem: rising antimicrobial resistance in building water systems	15
Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-19	15
Editorial introductions	15
The microbiota in respiratory tract infections: from association to intervention	15
The role of macrolides in severe community-acquired pneumonia and the potential impact of macrolide-resistant Mycoplamsa pneumoniae	14
Respiratory syncytial virus prevention in immunocompromised hosts: gaps and opportunities	14
Editorial: Pathogenesis and immune response – editorial	14
Combatting antimicrobial-resistant Neisseria gonorrhoeae: new antibiotics and the pipeline of antigonococcal therapeutics	14
Childhood tuberculosis	14
Interpreting and managing preservation fluids positive for Gram-negative bacteria	14
The secret weapon to reduce multidrug-resistant Gram-negative infections: can vaccines help decrease MDR risk?	14
Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis	13
An overview of risk factors, management and prevention of cochlear implant infections	13
New trends in congenital syphilis: epidemiology, testing in pregnancy, and management	13
Data science for pediatric infectious disease: utilizing COVID-19 as a model	13
Human adenovirus lung disease: outbreaks, models of immune-response-driven acute lung injury and pandemic potential	13
Travellers’ diarrhoea – solidifying our knowledgebase	13
Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectives	12
The microbiome as a biomarker of anal precancerous lesions in people with HIV	12
Antiviral therapies for respiratory syncytial virus infection: current expectations	12
The disease burden of respiratory syncytial virus in Infants	12
H5 and H9 avian influenza – potential re-emergent zoonotic threats to humans	12
Advanced neuroimaging for central nervous system infections: when, where, how, and why?	11
Update on drug treatments for multidrug resistant tuberculosis	11
Identifying patients with difficult-to-treat acute bacterial skin infections	11
Chronic persistent Norovirus in the immune-compromised host	11
Short treatment duration for community-acquired pneumonia	11
Respiratory metagenomics: route to routine service	11

Emerging treatment options for skin and soft tissue infections tailoring drug selection to individual patients	11
Genetic mechanisms underlying host susceptibility to central nervous system viral infections	11
A new era of HIV care for age-associated multimorbidity	10
Short-course antibiotic strategies for ventilator-associated pneumonia	10
Resurgence of Mycoplasma pneumoniae infections in children: emerging challenges and opportunities	10
Immune responses and severe dengue: what have we learned?	10
Urinary tract infections in immunocompromised patients	10
Anti-inflammatory therapies for bronchiectasis	10
Latent tuberculosis screening and treatment in solid organ and hematopoietic stem cell transplant candidates and recipients	10
Skin and soft tissue infections in solid organ transplants	10
Neurobrucellosis	10
Burden of influenza in the elderly: a narrative review	10
Updates on the neurological manifestations of SARS-CoV-2 infection	10